Severe, systemic GVHD observed following BMT with Dnmt3a-KO donors was associated with increased histopathology scores in the gut (small and large intestine) and liver, but not skin, compared with allogeneic controls (Figure 1D). The gene discussed is DNMT3A; the disease is graft versus host disease.